TrialRecent patents on anti-cancer drug discovery2022

Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response.

Charles L Wiseman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.